Protopic, Tacrolimus News

National report - Dermatologists can treat patients with keloids more effectively due to new treatment choices, according to an expert who treats patients who have darker skin.

Main Category: Eczema / Psoriasis Also Included In: Dermatology Article Date: 25 May 2009 - 1:00 PDT Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals.

PROTOPIC ointment in a new twice-weekly regimen can help prevent eczema flares Prague, Czech Republic, Thursday 21st May Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals.

You get an itchy rash, and it's not the first time. Maybe you're wondering if it's eczema or perhaps seborrheic dermatitis.

Atopic dermatitis is one of the most common inflammatory skin diseases among children and adults.

Atopic dermatitis, the common, chronic, inflammatory skin disease marked by red, itchy rashes, has been increasing in prevalence over the past two decades and affects a disproportionate number of children.

A sequential regimen of tacrolimus ointment and tapered use of topical corticosteroids in children may provide control of atopic dermatitis while limiting exposure to corticosteroids, according to research ...

Pruritus, sleep disturbance and general quality of life all improve with topical tacrolimus added to first-line treatment for children with atopic dermatitis.

Astellas Pharma Europe Ltd announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion, recommending the approval of a twice-weekly ...